Delivery Order SPE2DB22D9367-SPE2DB23FSZ58
Award Date 8/8/23
Potential Completion Date 8/29/23
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order under an unspecified contract vehicle to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 500 vials of KCENTRA, a blood coagulation factor, with a potential value of $8,071.20. Performance will take place in Park Ridge and be completed by June 23, 2023. The award was made on June 1, 2023 with no set-aside designation specified. As the DLA supports military treatment facilities, this order will likely provide needed...
- The Defense Logistics Agency Troop Support Medical awarded a $21,888 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562568814 KCENTRA 500 unit vials to be delivered by October 31, 2023. No set-aside designation was used for this award placed against an unspecified governmentwide acquisition contract vehicle. DMS Pharmaceutical Group will provide the intravenous administration of four coagulation factors to the Defense Logistics...
- The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $18,720.90 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of KCENTRA to be delivered to a location in Park Ridge, Illinois, with performance required between September 29, 2023 and October 23, 2023. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate indicated for the urgent reversal of acquired coagulation factor...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $118,468.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 1,000 vials of Kcentra. Kcentra is a four-factor prothrombin complex concentrate used to treat patients with acquired coagulation factor deficiency. DMS Pharmaceutical will deliver the Kcentra vials to a location in Park Ridge, Illinois by August 15, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $16,324.80 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of Kcentra to be delivered to a location in Park Ridge, Illinois. Performance will take place between June 29, 2023 and July 21, 2023 to supply the requested pharmaceutical product in support of the Agency's medical logistics programs. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,205.76 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities...
- The Defense Logistics Agency awarded a delivery order valued at $17,008.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. The delivery order, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, operates under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc. is performing at its Park...
- The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at approximately $5,965 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the terms of the order, DMS will provide 1,000 vials of Kcentra to the DLA. Kcentra is an injection used to treat patients with severe bleeding or those at risk of bleeding who require an urgent procedure. The order has a period of performance beginning on September 29, 2023...
- The Defense Logistics Agency (DLA), an agency of the United States Department of Defense, awarded a firm fixed price delivery order valued at twenty-eight thousand seven hundred eighty-two dollars and seventy-two cents ($28,782.72) to DMS Pharmaceutical Group Inc. as prime contractor. The order is for one thousand (1,000) vial units of Kcentra to be delivered to a location in Park Ridge, Illinois. The period of performance is from July 23, 2023 through August 11, 2023. No subcontractors or set...
- The Defense Logistics Agency Troop Support Medical awarded a $22,812 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562179656 KCENTRA 500 unit vials. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and medical supplies. This delivery order falls under an indefinite-delivery/indefinite-quantity contract vehicle and provides 500 vials of Kcentra, a four-factor prothrombin complex concentrate used to treat patients with acquired...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB23FSZ58Delivery Order
The Defense Logistics Agency awarded a $21,386 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to provide 4561904713 AB PT CMPLX CONC KCENTRA LAB services at a place of performance in Park Ridge, Illinois. The order was issued against an unspecified governmentwide acquisition contract vehicle to supply the concentrated solution used in treating patients with severe bleeding or coagulation problems from warfarin over-anticoagulation. Work under the order is to be completed by August 29, 2023 to support the DLA's medical supply chain requirements. No subcontractors or set aside designations were identified.
Generated 12/22/23, 8:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 8/8/23 |